MEDICAL

Newborn Screening Programme in UK

Interview with Meena Balasubramanian My name is Meena Balasubramanian. I am a clinician-scientist specialising in bone genetics at the University of Sheffield and Sheffield Children’s Hospital in the UK. I have worked in Sheffield over the last 15 years. I started here as a Clinical Genetics trainee having previously worked as a paediatrician and did my…

READ MORE
LaboratoryMEDICAL

Free genetic testing

Do you need a genetic test, but have problems accessing it? The Discover Dysplasias® program provides individuals suspected of having an inherited skeletal dysplasia (incl. OI) access to high-quality genetic testing. Early access to testing can enable an accurate diagnosis, which can lead to improved patient outcomes. Blueprint Genetics and BioMarin collaborate to offer a…

READ MORE
RESEARCH

Fetal diagnosis of OI during pregnancy

Interview with Shannon Bonner, graduate student of genetic counseling at Baylor College of Medicine, Houston, Texas, USA Who are you & what is your relationship to OI? My name is Shannon Bonner and I am currently a graduate student studying genetic counseling at Baylor College of Medicine which is located in Houston, Texas. In the…

READ MORE
CONFERENCES

OIFE at RBD Summit

On December 6th three representatives from OIFE took part in the first edition of the Rare Bone Disease (RBD) Summit: Oliver Semler Ingunn Westerheim Inger-Margrethe Stavdal Paulsen On December 14th we will attend the second half of the two half-day multi-stakeholder meeting. The RBD (Rare Bone Disease) Summit is a global multi-stakeholder group meeting that aims to provide a platform…

READ MORE
ADVOCACY

The IMPACT Survey is live – spread the word!

The IMPACT Survey is a joint initiative between the umbrella organization Osteogenesis Imperfecta Federation Europe (OIFE), the OI Foundation & the pharma company Mereo BioPharma. Together we’re delighted to announce that English version of The IMPACT Survey is now live and will be running until 10th September 2021. Next week we will also launch the survey…

READ MORE
ADVOCACY

RARE2030 – Survey to shape future policy

We need your help! OIFE and EURORDIS need your opinion on future policy for people with OI and other rare diseases! If enough people with OI worldwide provide an answer to this survey, it will help us shape the future of rare disease policies regarding access to health care, medical and social research and diagnosis…

READ MORE
Translate »